TIGIT and acute myeloid leukemia: Likewise, blockade of TIGIT, CD39, and A2AR checkpoints on NK cells purified from peripheral blood (n = 15) and bone marrow (n = 25) of AML patients increased the cytotoxic function of NK cells [78].